why choose us

First received: July 27, 2023

Clinical Trial: Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Bladder Cancer

Study Type: OBSERVATIONAL


Official Title: Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Brief Summary: BCDx is a urine-based multi-omic assay for early cancer recurrence detection in patients with a history of bladder cancer.This prospective, blinded study evaluates its efficacy in detecting recurrent NMIBC, offering a noninvasive monitoring solution.

Read more